Martial Descoutures
Stock Analyst at Oddo BHF
(2.93)
# 2,773
Out of 4,707 analysts
17
Total ratings
77.8%
Success rate
13.9%
Average return
Main Sectors:
Stocks Rated by Martial Descoutures
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: ABVX ABIVAX Société Anonyme | Maintained: Buy | €120.00 | €101.00 | +18.81% | 1 | Apr 9, 2026 | |
| SWX: SDZ Sandoz Group AG | Initiated Coverage: Hold | CHF 57.00 | CHF 68.20 | -16.42% | 1 | Dec 18, 2025 | |
| LON: 0QIU Novo Nordisk A/S | Downgraded: Hold | kr 910.00 → kr 465.00 | kr 292.00 | n/a | 2 | Jul 30, 2025 | |
| LON: 0NZT UCB SA | Upgraded: Buy | €107.00 → €168.00 | €206.95 | n/a | 2 | Jul 26, 2024 | |
| NVS Novartis AG | Downgraded: Hold | n/a | $137.70 | n/a | 2 | Mar 13, 2024 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $45.16 | n/a | 1 | Mar 13, 2024 | |
| LON: GSK GSK plc | Upgraded: Buy | 1,490p → 1,700p | 1,797p | n/a | 2 | Sep 29, 2022 | |
| SWX: NOVN Novartis AG | Downgraded: Hold | CHF 93.00 → CHF 88.00 | CHF 111.80 | n/a | 2 | Sep 28, 2022 | |
| BIT: REC Recordati Industria Chimica e Farmaceutica S.p.A. | Upgraded: Hold | €42.00 | €51.95 | n/a | 2 | Jul 29, 2022 | |
| SWX: ROP Roche Holding AG | Upgraded: Buy | n/a | $350.50 | n/a | 1 | Mar 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €94.00 | €74.70 | n/a | 1 | Jul 29, 2019 |
ABIVAX Société Anonyme
Apr 9, 2026
Maintained: Buy
Price Target: €120.00
Current: €101.00
Upside: +18.81%
Sandoz Group AG
Dec 18, 2025
Initiated Coverage: Hold
Price Target: CHF 57.00
Current: CHF 68.20
Upside: -16.42%
Novo Nordisk A/S
Jul 30, 2025
Downgraded: Hold
Price Target: kr 910.00 → kr 465.00
Current: kr 292.00
Upside: n/a
UCB SA
Jul 26, 2024
Upgraded: Buy
Price Target: €107.00 → €168.00
Current: €206.95
Upside: n/a
Novartis AG
Mar 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $137.70
Upside: n/a
Novo Nordisk
Mar 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $45.16
Upside: n/a
GSK plc
Sep 29, 2022
Upgraded: Buy
Price Target: 1,490p → 1,700p
Current: 1,797p
Upside: n/a
Novartis AG
Sep 28, 2022
Downgraded: Hold
Price Target: CHF 93.00 → CHF 88.00
Current: CHF 111.80
Upside: n/a
Recordati Industria Chimica e Farmaceutica S.p.A.
Jul 29, 2022
Upgraded: Hold
Price Target: €42.00
Current: €51.95
Upside: n/a
Roche Holding AG
Mar 31, 2020
Upgraded: Buy
Price Target: n/a
Current: $350.50
Upside: n/a
Jul 29, 2019
Maintained: Buy
Price Target: €94.00
Current: €74.70
Upside: n/a